Daiwa Securities Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.07M | Buy |
14,045
+1,369
| +11% | +$300K | 0.01% | 533 |
|
|
2025
Q1 | $2.84M | Buy |
12,676
+1,163
| +10% | +$260K | 0.01% | 511 |
|
|
2024
Q4 | $3.77M | Buy |
11,513
+643
| +6% | +$211K | 0.02% | 442 |
|
|
2024
Q3 | $3.26M | Buy |
10,870
+857
| +9% | +$257K | 0.02% | 465 |
|
|
2024
Q2 | $3.3M | Buy |
10,013
+1,273
| +15% | +$419K | 0.02% | 430 |
|
|
2024
Q1 | $3.46M | Buy |
8,740
+753
| +9% | +$298K | 0.02% | 409 |
|
|
2023
Q4 | $2.81M | Buy |
7,987
+739
| +10% | +$260K | 0.02% | 432 |
|
|
2023
Q3 | $2.72M | Buy |
7,248
+568
| +9% | +$213K | 0.02% | 419 |
|
|
2023
Q2 | $2.56M | Buy |
6,680
+268
| +4% | +$103K | 0.02% | 430 |
|
|
2023
Q1 | $2.22M | Buy |
6,412
+602
| +10% | +$209K | 0.02% | 465 |
|
|
2022
Q4 | $1.37M | Buy |
5,810
+846
| +17% | +$199K | 0.01% | 559 |
|
|
2022
Q3 | $1.22M | Buy |
4,964
+212
| +4% | +$52.2K | 0.01% | 579 |
|
|
2022
Q2 | $1.44M | Buy |
4,752
+176
| +4% | +$53.2K | 0.01% | 542 |
|
|
2022
Q1 | $1.88M | Buy |
4,576
+236
| +5% | +$96.9K | 0.01% | 518 |
|
|
2021
Q4 | $2.04M | Buy |
4,340
+199
| +5% | +$93.4K | 0.01% | 506 |
|
|
2021
Q3 | $1.76M | Buy |
4,141
+171
| +4% | +$72.6K | 0.01% | 525 |
|
|
2021
Q2 | $1.43M | Buy |
3,970
+194
| +5% | +$69.7K | 0.01% | 551 |
|
|
2021
Q1 | $1.06M | Buy |
3,776
+165
| +5% | +$46.5K | 0.01% | 589 |
|
|
2020
Q4 | $1.02M | Buy |
3,611
+67
| +2% | +$19K | 0.01% | 566 |
|
|
2020
Q3 | $974K | Buy |
3,544
+492
| +16% | +$135K | 0.01% | 512 |
|
|
2020
Q2 | $465K | Hold |
3,052
| – | – | 0.01% | 553 |
|
|
2020
Q1 | $465K | Hold |
3,052
| – | – | ﹤0.01% | 662 |
|
|
2019
Q4 | $459K | Buy |
+3,052
| New | +$459K | ﹤0.01% | 731 |
|